To include your compound in the COVID-19 Resource Center, submit it here.

Vatiquinone alpha-tocotrienol quinone: Phase II data

A double-blind, Italian Phase II trial in 24 female Rett syndrome patients ages 2.5-8 showed that thrice-daily 15 mg/kg EPI-743 missed the primary endpoint of improving the Rett

Read the full 286 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE